85-1556-99 FGF-4, Recombinant, Mouse (Fibroblast Growth Factor 4, Heparin-binding Growth Factor 4, HBGF-4, K-fibroblast Growth Factor, Fgf4, Fgf-4, Kfgf) (BSA Free) 25ug F4210-50C

※お見積書はカートで印刷できます

冷凍 保管・搬送時に冷凍が必要な商品です。

特徴

  • Ffibroblast growth factor-4, also known as FGF-K or K-FGF (Kaposi’s sarcoma-associated FGF), is a 25kD secreted, heparin-binding member of the FGF family. The mouse FGF-4 cDNA encodes 202aa with a 29aa signal sequence and a 173aa mature protein with an FGF homology domain that contains a heparin binding region near the C-terminus. Mature mouse FGF-4 shares 87%, 90%, 87% and 85% aa identity with human, rat, canine and bovine FGF-4, respectively. Human FGF-4 has been shown to exhibit cross species activity. Expression of FGF-4 and its receptors, FGF R1c, 2c, 3c and 4, is spatially and temporally regulated during embryonic development. Its expression in the trophoblast inner cell mass promotes expression of FGF R2, and is required for maintenance of the trophectoderm and primitive endoderm. Later in development, FGF-4 works together with FGF-8 to mediate the activities of the apical ectodermal ridge, which direct the outgrowth and patterning of vertebrate limbs. FGF-4 is proposed to play a physiologically relevant role in human embryonic stem cell self-renewal. It promotes stem cell proliferation, but may also aid differentiation depending on context and concentration, and is often included in embryonic stem cell media in vitro. A C-terminally truncated 15kD isoform that opposes full-length FGF-4 and promotes differentiation is endogenously expressed in human embryonic stem cells. FGF-4 is mitogenic for fibroblasts and endothelial cells in vitro and has autocrine transforming potential. It is a potent angiogenesis promoter in vivo and has been investigated as therapy for coronary artery disease.
  • Source:Recombinant mouse FGF-4, expressed in E.coli (Ala30-Leu202)
  • SDS-PAGE: 19kD, reducing conditions
  • Activity: Measured in a cell proliferation assay using NR6R-3T3 mouse fibroblasts. The ED50 for this effect is typically 0.75-3.75ng/ml.
  • Storage and Stability:Lyophilized powder may be stored at -20°C. Stable for 12 months at -20°C. Reconstitute with sterile buffer or ddH2O. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Reconstituted product is stable for 6 months at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.

仕様

  • Size:25ug
  • Source Antigen:Recombinant, E. coli
  • Grade:Highly Purified
  • Purity:~95% (SDS-PAGE). Endotoxin: <1.0 EU/1ug (LAL).
  • Form:Supplied as a lyophilized powder from a 0.2um filtered solution in MOPS, ammonium sulfate, EDTA, DTT. Reconstitute with 250ul sterile PBS.
  • Molecular Weight Non Ab:19
  • EU Commodity Code:30021019
  • この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
  • 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。
  • 【試薬に関するお問合せ】
  • アズワン株式会社 試薬・プロセス材料グループ
  • TEL:06-6447-8641
  • FAX:06-6447-8642
  • E-mail:[email protected]
アズワン品番
85-1556-99
型番
F4210-50C
入り数
1個
標準価格
202,000円(税抜)
WEB価格
アズワン在庫 [?]
数量

※お気に入り機能はログイン後にご利用いただけます

よくあるご質問

よくあるご質問(FAQ)

掲載カタログ情報

掲載カタログ名 掲載ページ

次の商品を登録しました。

商品計:

お買い物を続ける カートを見る